Tag: Medicare Part B reimbursement
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Medications
Archives
Recent-posts
Black Box Warnings: What You Need to Know About the FDA’s Strongest Drug Safety Alerts
Nov, 19 2025
Bupropion vs. Other Antidepressants: A Comparative Analysis
Nov, 9 2023
Prescriber Education Resources: Essential Guides for Doctors on Generic Medications
Jan, 7 2026
Generic Drug Contamination Risks: How to Prevent and Respond to Unsafe Medications
Nov, 14 2025
Biltricide (Praziquantel) vs Alternative Anthelmintics: A Practical Comparison
Sep, 25 2025